 |
 |
|
|
RESÚMENES FEBRERO 2005 |
Other Neuropsychiatric Disorders & General Information
(Requiere estar conectado a internet. Haga un click en la
información del journal)
A preclinical view
of cholinesterase inhibitors in neuroprotection: do they provide more than
symptomatic benefits in Alzheimer's disease?
Paul T. Francis,
Agneta Nordberg and Steven E. Arnold
Trends in Pharmacological Sciences. Volume 26, Issue
2, February 2005, Pages 104-111
Neuropsychology
of Vitamin B12 Deficiency in Elderly Dementia Patients and Control
Subjects
Alicia Osimani, Andrea Berger, Joshua Friedman, Bat-Sheba Porat-Katz,
Jacob M. Abarbanel
Journal of Geriatric Psychiatry and Neurology, Vol.
18, No. 1, 33-38 (2005)
JIRI MODESTIN, AND OTHMAR WUERMLE
Psychiatry and Clinical Neurosciences Volume
59 Issue 1 Page 25 - February 2005
LAURA CURRIN, ULRIKE SCHMIDT, JANET TREASURE, HERSHEL JICK
The British Journal of Psychiatry (2005) 186: 132-135
Efficacy of
cognitive behavioral therapy and fluoxetine for the treatment of binge eating
disorder: A randomized double-blind placebo-controlled comparison
Carlos M. Grilo,
Robin M. Masheb and G. Terence Wilson
Biological Psychiatry. Volume 57, Issue 3, 1 February
2005, Pages 301-309
Obesity and Associated Complications in Patients With Severe Mental Illnesses: A Cross-Sectional Survey
Margaret T. Susce,
Noemi Villanueva, Francisco J. Diaz, and Jose de Leon
J Clin Psychiatry 2005;66:167-173
Blood Pressure Changes Associated With Medication
Treatment of Adults With Attention-Deficit/Hyperactivity Disorder
Timothy E. Wilens,
Paul G. Hammerness, Joseph Biederman, Anne Kwon, Thomas J. Spencer, Sarah
Clark, Megan Scott, Amy Podolski, Jeffrey W. Ditterline, Matthew C. Morris, and
Hadley Moore
J Clin Psychiatry 2005;66:253-259
Pharmacological Treatment of Neuropsychiatric Symptoms of
Dementia. A Review of the Evidence
Kaycee
M. Sink, Karen F. Holden, Kristine Yaffe
Fusun Yaris, Cunay
Ulku, Murat Kesim, Mine Kadioglu, Mesut Unsal, Mustafa Fevzi Dikici, Nuri Ihsan
Kalyoncu and Ersin Yaris
Serotonergic and dopaminergic systems in anorexia nervosa: a role for
atypical antipsychotics?
Peter Bosanac , Trevor Norman, Graham Burrows,
Peter Beumont
Australian and New Zealand Journal of Psychiatry.
Volume 39 Issue 3 Page 146 - March 2005
D. Justo, V. Prokhorov, K. Heller, D. Zeltser
Acta Psychiatrica Scandinavica. Volume 111 Issue
3 Page 171 - March 2005
The effects of diazepam on human self-aggressive behavior
Mitchell E. Berman,
Gabriele D. Jones and Michael S. McCloskey
Psychopharmacology 2005; Volume 178, Number
1: 100 - 106
Risto Vataja, Tarja Pohjasvaara, Riitta Mäntylä, Raija Ylikoski, Maarit
Leskelä, Hely Kalska, Marja Hietanen, Hannu Juhani Aronen, Oili Salonen, Markku
Kaste, Antero Leppävuori, and Timo Erkinjuntti
Am J Geriatr Psychiatry
13:99-107, February 2005
Premenstrual dysphoric symptoms amongst Brazilian college students:
factor structure and methodological appraisal
Chei-Tung Teng,
A. H. G. Vieira Filho, R. Artes, C. Gorenstein,
L. H. Andrade and Y.-P. Wang
European Archives of Psychiatry and Clinical
Neuroscience 2005; Volume 255, Number 1: 51 - 56
Age and gender
effects on the pharmacokinetics and pharmacodynamics of triazolam, a cytochrome
P450 3A substrate
David J.
Greenblatt, Jerold S. Harmatz, Lisa L. von Moltke, C.Eugene Wright and Richard
I. Shader
Clinical Pharmacology & Therapeutics. Volume 76,
Issue 5, November 2004, Pages 467-479
Antidepressant
effects on aggressive, self-injurious and destructive/disruptive behaviours in
intellectually disabled adults: a retrospective, open-label, naturalistic trial
David
S. Janowsky, Mahesh Shetty, Jarrett Barnhill, Belal Elamir
and John M. Davis
The International Journal of Neuropsychopharmacology
(2005), 8:1:37-48 Serotonergic
Marco Duering,
Marcus O.W. Grimm, Heike S. Grimm, Johannes Schröder and Tobias Hartmann
Neurobiology of Aging. Volume 26, Issue 6, June 2005,
Pages 785-788
Michael
S. McCloskey, K. Luan Phan and Emil F. Coccaro
Current Psychiatry Reports 2005, 7:65-72
Levodopa Challenge Neuroimaging of Levodopa-Related Mood
Fluctuations in Parkinson's Disease
Kevin J Black, Tamara Hershey,
Johanna M Hartlein, Juanita L Carl and Joel S Perlmutter
Neuropsychopharmacology (2005) 30, 590-601
Neurocognitive effects of methylphenidate in adult
attention-deficit/hyperactivity disorder
Danielle C. Turner,
Andrew D. Blackwell, Jonathan H. Dowson, Andrew McLean
and Barbara J. Sahakian
Psychopharmacology 2005; Volume 178, Numbers
2-3: 286 - 295
Risperidone in
the treatment of behavioural and psychological symptoms of dementia in patients
diagnosed with vascular or mixed-type dementia
Alfonso J. Cruz-Jentoft,
José-Antonio Burón, Jesús I. Diago, Ricardo Gallego
International Journal of Psychiatry in Clinical
Practice. Volume 9, Number 1 / March 2005 : 45 - 51
Plasma cortisol levels, brain volumes
and cognition in healthy elderly men
Alasdair M.J.
MacLullich, Ian J. Deary, John M. Starr, Karen J. Ferguson, Joanna M. Wardlaw
and Jonathan R. Seckl
Psychoneuroendocrinology. Volume 30, Issue 5, June
2005, Pages 505-515
Is benzodiazepine
use a risk factor for cognitive decline and dementia? A literature review of
epidemiological studies
HELENE VERDOUX,
RAJAA LAGNAOUI and BERNARD BEGAUD
Psychological Medicine (2005), 35:3:307-315
Lifetime risk and
persistence of psychiatric disorders across ethnic groups in the United States
JOSHUA BRESLAU,
KENNETH S. KENDLER, MAXWELL SU, SERGIO GAXIOLA-AGUILAR and RONALD
C. KESSLER
Psychological Medicine (2005), 35:3:317-327
Restricted fetal
growth and adverse maternal psychosocial and socioeconomic conditions as risk
factors for suicidal behaviour of offspring: a cohort study
E
Mittendorfer-Rutz, F Rasmussen and D Wasserman
The Lancet. Volume 364, Issue 9440, 25 September
2004-1 September 2004, Pages 1135-1140
Matthew S.
Stanford, Laura E. Helfritz, Sarah M. Conklin, Nicole R. Villemarette-Pittman,
Kevin W. Greve, Donald Adams and Rebecca J. Houston
Experimental and Clinical Psychopharmacology. Volume 13, Issue 1, February 2005, Pages 72-77
.